market
GLP‑1 Therapies and the exploding weight‑loss supplement market: Data‑driven insights for nutrition professionals
GLP-1 therapies now capture roughly 18 % of new weight-loss prescriptions in the United States, making them the fastest-growing segment of the prescription-driven market. This surge is prompting insurers and consumers to seek nutrition programs that amplify hormone-based results, turning the medication-diet interface into a high-value growth frontier. Medical Disclaimer: This